USA: Selected acute medications (e.g., ergots, anti-emetics, triptans) are associated with higher odds of user-rated positive response versus ibuprofen for patients with migraine, a recent study published in Neurology has shown. Using a big-data approach, the researchers analyzed patient-generated real-time records of 10 million migraine attacks, and simultaneous head-to-head comparisons of 25 acute migraine medications […]
A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects. The findings from the multinational SHAMAL study, published in The Lancet, demonstrated that 92% of patients using the biologic therapy benralizumab could safely reduce inhaled steroid dose […]
A recent systematic review and meta-analysis exploring the relationship between vitamin D levels and noninfectious uveitis have revealed a striking association. The findings suggest that individuals with vitamin D deficiency face more than a twofold increased risk of developing noninfectious uveitis compared to those without such deficiency. This study was published in the Autoimmunity Reviews […]
A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. While the study doesn’t answer the question of whether cell therapy in remission is […]
A recent investigation examined the combined influence of metabolic syndrome (MetS) and obesity on markers of early atherosclerosis—carotid artery intima media thickness (cIMT) and adventitial diameter (AD). This study was published in the Menopause journal by Leis and colleagues. Carotid ultrasound assessments conducted as part of the Study of Women’s Health Across the Nation (SWAN) […]
New Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the trial of the Rilvegostomig (AZD2936) concentrate for solution for infusion to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator’s choice of chemotherapy […]
The day following a two-hour pen-down strike at government health facilities, Haryana Health Department’s medical professionals announced on Sunday their intention to launch an indefinite strike from December 29 if their demands remained unmet within two weeks. This decision was reached during the core committee meeting of the Haryana Civil Medical Services Association (HCMSA), the […]
Korea: Deferral of percutaneous coronary intervention (PCI) based on intravascular ultrasound (IVUS) guided treatment decision showed a comparable risk of clinical events with fractional flow reserve (FFR)-guided treatment decision in patients with intermediate coronary artery stenosis, a recent study has shown. Findings from the post-hoc analysis of 2-year data from the FLAVOUR trial were presented […]
The Madras High Court recently asked the Insurance Regulatory and Development Authority of India (IRDAI) to treat AYUSH treatment on par with Allopathic treatment while reimbursing expenses incurred during treatment. IRDAI has also been directed to reimburse the insurance amount on equal scales for both branches of medicine. “There shall be a direction to the […]
Melasma, a challenging hyperpigmentation disorder, often poses therapeutic dilemmas due to its intricate pathogenesis, recurrence tendencies, and substantial morbidity impact. In a bid to revolutionize treatment outcomes, a comprehensive network meta-analysis (NMA) has scrutinized various laser-related therapies, shedding light on the most effective approaches for managing melasma. This study was published in Journal Of Cosmetic […]